Celularity (CELU) executive Kilcoyne gave up 52,762 shares at $0.43 to cover taxes or an exercise price
Insider transactions reported
Adrian Kilcoyne (Chief Medical Officer at Celularity Inc., CELU) reported that they gave up 52,762 shares at $0.43 to cover taxes or an exercise price between Feb 16, 2024 and Feb 17, 2024. After these transactions the filing shows 1,122,238 shares held directly.
- Reporting person
- Kilcoyne Adrian
- Role
- Chief Medical Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 17, 2024 | Shares withheld for taxes or exercise price (F) | Class A Common Stock1, 2 | -52,762 | $0.43 | $22.9K | 1,122,238 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 16, 2024 | Grant or award (A) | Stock Option Grant (Right to Buy)On 205,213 Class A Common Stock3 | +205,213 | - | - | 205,213 direct |
Holdings before and after
- Class A Common Stock: 1,175,000 to 1,122,238 direct
- Stock Option Grant (Right to Buy): 0 to 205,213 direct
Footnotes from the filing
- 1. Represents shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting and settlement of restricted stock units ( RSUs ) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan ) and does not represent a sale.
- 2. Reflects shares underlying RSUs subject to vesting.
- 3. The option was granted pursuant to the 2021 Plan. The shares underlying such option will vest in equal quarterly installments during 2024 such that 25% of the option will vest on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person's continuous service with the Issuer through each such date.
Transaction codes in this filing
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Kilcoyne report in this CELU Form 4?
Adrian Kilcoyne (Chief Medical Officer at Celularity Inc., CELU) reported that they gave up 52,762 shares at $0.43 to cover taxes or an exercise price between Feb 16, 2024 and Feb 17, 2024. After these transactions the filing shows 1,122,238 shares held directly.
How many CELU shares does Kilcoyne hold after this filing?
The filing shows 1,122,238 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code F mean on an SEC Form 4?
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
Historical context for CELU
Earlier insider filings at CELU
- Feb 22, 2024Haines John R covered exercise/tax liability with 70,350 shares, decreasing direct ownership by 15% to 389,497 units (SEC Form 4)
- Feb 22, 2024Beers David C covered exercise/tax liability with 43,968 shares, decreasing direct ownership by 15% to 243,437 units (SEC Form 4)
- Feb 22, 2024Brigido Stephen covered exercise/tax liability with 32,720 shares, decreasing direct ownership by 14% to 197,406 units (SEC Form 4)
- Feb 22, 2024Fletcher Kyle covered exercise/tax liability with 39,571 shares, decreasing direct ownership by 15% to 217,228 units (SEC Form 4)
- Jan 17, 2024Lim Kok Thay bought $5,331,335 worth of shares (21,410,983 units at $0.25) (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2019
Follow CELU and get a push notification the moment its next story breaks.